Witryna8 mar 2024 · Archived Events. Date. Event Details. Mar 8, 2024 10:30 AM EST. 43rd Annual Cowen Health Care Conference. Listen to webcast. Feb 6, 2024 4:30 PM EST. Arrowhead Pharmaceuticals 2024 First Quarter Results. Listen to webcast. Witryna6 lip 2024 · Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune ...
Investor Relations Center - Handelsblatt Online
Witryna6 lis 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q3 2024 Earnings Conference Call November 3, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR and CommunicationsDaniel Vitt - CEO and... Witryna23 sie 2024 · Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. ... Head of Investor Relations and Communications. Standort. Größere Karte. Gräfelfing. Lochhamer Schlag 21, 82166 … ifly2fsuipc
Pfizer Inc. - Investor Relations - Events & Presentations
Witryna3 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … Witryna31 gru 2024 · Results of Operations. The Company reported a net loss of $41.5 million for the year ended December 31, 2024, which compared with a net loss of $52.1 million for the prior year. This resulted in a net loss of $0.98 per share for the year ended December 31, 2024, as compared to a net loss of $1.31 per share for 2024, on both a … Witryna2 dni temu · Telenor ASA appointed Frank Maao as senior vice president for capital markets and investor relations, according to a statement. Maao comes from the … is sssniperwolf alive 2022